Literature DB >> 16794790

Influence of Japan's new Diagnosis Procedure Combination-based payment system on the surgical sector: does it really shorten the hospital stay?

Hideo Yasunaga1, Hiroo Ide, Tomoaki Imamura, Kazukiko Ohe.   

Abstract

PURPOSE: In 2003, the Diagnosis Procedure Combination (DPC)-based payment system was introduced on a trial basis in 82 major Japanese hospitals. We analyzed the influence of this system on hospital revenue and expenditure, focusing on whether it reduces the length of stay in hospital (LOS), particularly in the surgical sector.
METHODS: We studied 120 patients hospitalized at the University of Tokyo hospital between May and July 2003, including 93 surgical patients who underwent operations for gastric, colon, rectal, hepatic, or mammary carcinoma; arteriosclerosis obliterans; appendicitis; adult hernia inguinalis; or varicose veins, and 27 nonsurgical patients hospitalized for recurrent gastric carcinoma, ileus, appendicitis, or mild acute pancreatitis. We analyzed the changes in profit per day in patients with a reduced LOS using the simulation model.
RESULTS: Reducing the LOS of the surgical patients resulted in a greater profit; however, there was minimal if any profit increase achieved by reducing the LOS of the medical patients. In fact, when material costs were high, profit decreased.
CONCLUSION: The DPC-based payment system does not usually offer an economic incentive to shorten the LOS. Expanding our current system will reduce the LOS only in major hospitals, but it will reduce the national average LOS. Thus, the current DPC-based payment system needs to be improved further.

Entities:  

Mesh:

Year:  2006        PMID: 16794790     DOI: 10.1007/s00595-006-3203-z

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  6 in total

1.  [The role of the critical path in a new hospital payment system according to a diagnosis procedure combination in Japan].

Authors:  Kenichi Hakamada; Mutsuo Sasaki
Journal:  Gan To Kagaku Ryoho       Date:  2004-08

2.  [Case mix based payment and DPC from an international perspective].

Authors:  Shinya Matsuda
Journal:  Gan To Kagaku Ryoho       Date:  2004-08

3.  [Management of hospitals in the prospective payment system].

Authors:  Toshiro Konishi
Journal:  Gan To Kagaku Ryoho       Date:  2004-08

4.  Minimally invasive cardiac surgery: principle and prospects.

Authors:  H Matsuda
Journal:  Surg Today       Date:  1998       Impact factor: 2.549

5.  Impact of a clinical pathway and standardization of treatment for acute appendicitis.

Authors:  Kenji Takegami; Yonei Kawaguchi; Hiroshi Nakayama; Yoshiro Kubota; Hirokazu Nagawa
Journal:  Surg Today       Date:  2003       Impact factor: 2.549

6.  Implementation of the diagnosis procedure combination in specific-function hospitals.

Authors:  Teruo Kiyama; Takashi Tajiri; Toshiro Yoshiyuki; Nobuhiko Taniai; Eiji Uchida; Akira Tokunaga
Journal:  J Nippon Med Sch       Date:  2004-06       Impact factor: 0.920

  6 in total
  6 in total

1.  A new accounting system for financial balance based on personnel cost after the introduction of a DPC/DRG system.

Authors:  Yoshiaki Nakagawa; Tadamasa Takemura; Hiroyuki Yoshihara; Yoshinobu Nakagawa
Journal:  J Med Syst       Date:  2009-08-27       Impact factor: 4.460

2.  New indicators based on personnel cost for management efficiency in a hospital.

Authors:  Yoshiaki Nakagawa; Hiroyuki Yoshihara; Yoshinobu Nakagawa
Journal:  J Med Syst       Date:  2009-11-27       Impact factor: 4.460

3.  Are we lacking economic evaluations in gastric cancer treatment?

Authors:  Alyson L Mahar; Abraham El-Sedfy; Savtaj S Brar; Ana Johnson; Natalie Coburn
Journal:  Pharmacoeconomics       Date:  2015-02       Impact factor: 4.981

4.  Does functional outcome in acute ischaemic stroke patients correlate with the amount of free-radical scavenger treatment? A retrospective study of edaravone therapy.

Authors:  Yoshiko Unno; Makiko Katayama; Hideaki Shimizu
Journal:  Clin Drug Investig       Date:  2010       Impact factor: 2.859

5.  Renal Morbidity of 6% Hydroxyethyl Starch 130/0.4 in 9000 Propensity Score Matched Pairs of Surgical Patients.

Authors:  Hideki Miyao; Yoshifumi Kotake
Journal:  Anesth Analg       Date:  2020-06       Impact factor: 5.108

6.  Postoperative renal morbidity and mortality after volume replacement with hydroxyethyl starch 130/0.4 or albumin during surgery: a propensity score-matched study.

Authors:  Hideki Miyao; Yoshifumi Kotake
Journal:  J Anesth       Date:  2020-08-11       Impact factor: 2.078

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.